These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Clinicoradiologic response of neurologic tuberculous mass lesions in children treated with thalidomide.
    Author: van Toorn R, du Plessis AM, Schaaf HS, Buys H, Hewlett RH, Schoeman JF.
    Journal: Pediatr Infect Dis J; 2015 Feb; 34(2):214-8. PubMed ID: 25741973.
    Abstract:
    Neurologic tuberculous pseudoabscesses that clinically progress despite conventional antituberculosis therapy may be responsive to adjuvant thalidomide, a potent tumor necrosis factor-α inhibitor. In this study, the addition of thalidomide provided substantial clinical benefit in the majority of patients, and magnetic resonance imaging evolution of lesions from early-stage "T2 bright" with edema to "T2 black" represented a marker of cure.
    [Abstract] [Full Text] [Related] [New Search]